Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: Avanos Medical Q4 Adj. EPS $0.36 Misses $0.37 Estimate, Sales $173.30M Beat $170.43M Estimate

Author: Benzinga Newsdesk | February 20, 2024 08:01pm

Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.37 by 2.7 percent. This is a 20 percent decrease over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $173.30 million which beat the analyst consensus estimate of $170.43 million by 1.68 percent. This is a 4.57 percent decrease over sales of $181.60 million the same period last year.

Posted In: AVNS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist